Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol
Aim To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses. Methods Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile chi...
Gespeichert in:
Veröffentlicht in: | British journal of clinical pharmacology 2003-03, Vol.55 (3), p.234-240 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 240 |
---|---|
container_issue | 3 |
container_start_page | 234 |
container_title | British journal of clinical pharmacology |
container_volume | 55 |
creator | Kozer, Eran Evans, Sandra Barr, Joseph Greenberg, Revital Soriano, Ingrid Bulkowstein, Mordechai Petrov, Irena Chen‐Levi, Zehava Barzilay, Bernard Berkovitch, Matitiahu |
description | Aim
To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses.
Methods
Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status.
Results
Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively).
Conclusions
In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage. |
doi_str_mv | 10.1046/j.1365-2125.2003.01723.x |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1884208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BCP1723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</originalsourceid><addsrcrecordid>eNqNkU-P1CAYh4nRuOPqVzBcvNnKCwXagyY6WVeTTfSgZwKUTpn0zwQYd-rJ0579jH4SW2eyozcP5IW8z_sD8iCEgeRACvFqmwMTPKNAeU4JYTkBSVl-eIBW942HaEUYERmnHC7Qkxi3hAADwR-jC6CCkUrSFbq77vZJp9aPg3uJN-fDrx8_a7dzQ-2GhN3wfepdxHqo55X8ePD1XHGc6X3EfsAuTKkNo53SjDVh7LFtfVcHN-AUnE6uxrc-tbj1m3aJHqPDOx20dUn3Y_cUPWp0F92zU71EX99ffVl_yG4-XX9cv73JbCGBZRzA1I0pWFmZgpcGKOiKV7bUpuJ1bYx2pBQABQNpBGegCRENKxsjpRTUskv05pi725ve1Xb-XNCd2gXf6zCpUXv1b2fwrdqM3xSUZUFJOQeUxwAbxhiDa-5ngajFjdqqRYFaFKjFjfrjRh3m0ed_330ePMmYgRcnQEeruybowfp45grBpKzkzL0-cre-c9N_P0C9W39eduw3qxexIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kozer, Eran ; Evans, Sandra ; Barr, Joseph ; Greenberg, Revital ; Soriano, Ingrid ; Bulkowstein, Mordechai ; Petrov, Irena ; Chen‐Levi, Zehava ; Barzilay, Bernard ; Berkovitch, Matitiahu</creator><creatorcontrib>Kozer, Eran ; Evans, Sandra ; Barr, Joseph ; Greenberg, Revital ; Soriano, Ingrid ; Bulkowstein, Mordechai ; Petrov, Irena ; Chen‐Levi, Zehava ; Barzilay, Bernard ; Berkovitch, Matitiahu</creatorcontrib><description>Aim
To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses.
Methods
Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status.
Results
Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively).
Conclusions
In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.</description><identifier>ISSN: 0306-5251</identifier><identifier>EISSN: 1365-2125</identifier><identifier>DOI: 10.1046/j.1365-2125.2003.01723.x</identifier><identifier>PMID: 12630972</identifier><identifier>CODEN: BCPHBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Acetaminophen - administration & dosage ; antioxidant status ; Antioxidants - metabolism ; Biological and medical sciences ; Child ; Child, Preschool ; Clinical Toxicology ; Drug toxicity and drugs side effects treatment ; Erythrocytes - enzymology ; febrile children ; Female ; Glutathione - metabolism ; glutathione changes ; Glutathione Peroxidase - blood ; Glutathione Reductase - blood ; Glutathione Transferase - blood ; glutathione‐dependent enzymes ; Humans ; Infant ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Prospective Studies ; repeated paracetamol ; Superoxide Dismutase - blood ; Toxicity: digestive system</subject><ispartof>British journal of clinical pharmacology, 2003-03, Vol.55 (3), p.234-240</ispartof><rights>2003 INIST-CNRS</rights><rights>2003 Blackwell Publishing Ltd 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</citedby><cites>FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2125.2003.01723.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2125.2003.01723.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14637797$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12630972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kozer, Eran</creatorcontrib><creatorcontrib>Evans, Sandra</creatorcontrib><creatorcontrib>Barr, Joseph</creatorcontrib><creatorcontrib>Greenberg, Revital</creatorcontrib><creatorcontrib>Soriano, Ingrid</creatorcontrib><creatorcontrib>Bulkowstein, Mordechai</creatorcontrib><creatorcontrib>Petrov, Irena</creatorcontrib><creatorcontrib>Chen‐Levi, Zehava</creatorcontrib><creatorcontrib>Barzilay, Bernard</creatorcontrib><creatorcontrib>Berkovitch, Matitiahu</creatorcontrib><title>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</title><title>British journal of clinical pharmacology</title><addtitle>Br J Clin Pharmacol</addtitle><description>Aim
To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses.
Methods
Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status.
Results
Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively).
Conclusions
In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.</description><subject>Acetaminophen - administration & dosage</subject><subject>antioxidant status</subject><subject>Antioxidants - metabolism</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Toxicology</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Erythrocytes - enzymology</subject><subject>febrile children</subject><subject>Female</subject><subject>Glutathione - metabolism</subject><subject>glutathione changes</subject><subject>Glutathione Peroxidase - blood</subject><subject>Glutathione Reductase - blood</subject><subject>Glutathione Transferase - blood</subject><subject>glutathione‐dependent enzymes</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>repeated paracetamol</subject><subject>Superoxide Dismutase - blood</subject><subject>Toxicity: digestive system</subject><issn>0306-5251</issn><issn>1365-2125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU-P1CAYh4nRuOPqVzBcvNnKCwXagyY6WVeTTfSgZwKUTpn0zwQYd-rJ0579jH4SW2eyozcP5IW8z_sD8iCEgeRACvFqmwMTPKNAeU4JYTkBSVl-eIBW942HaEUYERmnHC7Qkxi3hAADwR-jC6CCkUrSFbq77vZJp9aPg3uJN-fDrx8_a7dzQ-2GhN3wfepdxHqo55X8ePD1XHGc6X3EfsAuTKkNo53SjDVh7LFtfVcHN-AUnE6uxrc-tbj1m3aJHqPDOx20dUn3Y_cUPWp0F92zU71EX99ffVl_yG4-XX9cv73JbCGBZRzA1I0pWFmZgpcGKOiKV7bUpuJ1bYx2pBQABQNpBGegCRENKxsjpRTUskv05pi725ve1Xb-XNCd2gXf6zCpUXv1b2fwrdqM3xSUZUFJOQeUxwAbxhiDa-5ngajFjdqqRYFaFKjFjfrjRh3m0ed_330ePMmYgRcnQEeruybowfp45grBpKzkzL0-cre-c9N_P0C9W39eduw3qxexIg</recordid><startdate>200303</startdate><enddate>200303</enddate><creator>Kozer, Eran</creator><creator>Evans, Sandra</creator><creator>Barr, Joseph</creator><creator>Greenberg, Revital</creator><creator>Soriano, Ingrid</creator><creator>Bulkowstein, Mordechai</creator><creator>Petrov, Irena</creator><creator>Chen‐Levi, Zehava</creator><creator>Barzilay, Bernard</creator><creator>Berkovitch, Matitiahu</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><general>Blackwell Science Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200303</creationdate><title>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</title><author>Kozer, Eran ; Evans, Sandra ; Barr, Joseph ; Greenberg, Revital ; Soriano, Ingrid ; Bulkowstein, Mordechai ; Petrov, Irena ; Chen‐Levi, Zehava ; Barzilay, Bernard ; Berkovitch, Matitiahu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4713-511bdfb4389b458b121a959c8ab95ddbbae086114317b6531a006f38fb77762c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acetaminophen - administration & dosage</topic><topic>antioxidant status</topic><topic>Antioxidants - metabolism</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Toxicology</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Erythrocytes - enzymology</topic><topic>febrile children</topic><topic>Female</topic><topic>Glutathione - metabolism</topic><topic>glutathione changes</topic><topic>Glutathione Peroxidase - blood</topic><topic>Glutathione Reductase - blood</topic><topic>Glutathione Transferase - blood</topic><topic>glutathione‐dependent enzymes</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>repeated paracetamol</topic><topic>Superoxide Dismutase - blood</topic><topic>Toxicity: digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kozer, Eran</creatorcontrib><creatorcontrib>Evans, Sandra</creatorcontrib><creatorcontrib>Barr, Joseph</creatorcontrib><creatorcontrib>Greenberg, Revital</creatorcontrib><creatorcontrib>Soriano, Ingrid</creatorcontrib><creatorcontrib>Bulkowstein, Mordechai</creatorcontrib><creatorcontrib>Petrov, Irena</creatorcontrib><creatorcontrib>Chen‐Levi, Zehava</creatorcontrib><creatorcontrib>Barzilay, Bernard</creatorcontrib><creatorcontrib>Berkovitch, Matitiahu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kozer, Eran</au><au>Evans, Sandra</au><au>Barr, Joseph</au><au>Greenberg, Revital</au><au>Soriano, Ingrid</au><au>Bulkowstein, Mordechai</au><au>Petrov, Irena</au><au>Chen‐Levi, Zehava</au><au>Barzilay, Bernard</au><au>Berkovitch, Matitiahu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol</atitle><jtitle>British journal of clinical pharmacology</jtitle><addtitle>Br J Clin Pharmacol</addtitle><date>2003-03</date><risdate>2003</risdate><volume>55</volume><issue>3</issue><spage>234</spage><epage>240</epage><pages>234-240</pages><issn>0306-5251</issn><eissn>1365-2125</eissn><coden>BCPHBM</coden><abstract>Aim
To investigate glutathione and antioxidant status changes in erythrocytes from febrile children receiving repeated supratherapeutic paracetamol doses.
Methods
Fifty‐one children aged 2 months to 10 years participated in the study. Three groups were studied: group 1 (n = 24) included afebrile children who did not receive paracetamol; and groups 2 (n = 13) and 3 (n = 14) included children who had fever above 38.5°C for more than 72 h. Patients in group 2 received paracetamol at a dose of 50 ± 15 (30–75) mg kg−1 day−1 and those in group 3 received paracetamol above the recommended therapeutic dose, ie 107 ± 28 (80–180) mg kg−1 day−1. A blood sample was taken for the measurement of liver transaminases, gammaglutamil transferase (GGT), reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPX), glutathione S‐transferase (GST), superoxide dismutase (SOD) and antioxidant status.
Results
Aspartate aminotransferase activity in group 3 was higher than in the other groups (P = 0.027). GSH, SOD and antioxidant status were significantly lower in group 3 compared with groups 1 and 2 (mean differences: for GSH 3.41 µmol gHb−1, 95% confidence interval (CI) 2.10–4.72, and 2.15 µmol gHb−1, 95% CI 0.65–3.65, respectively; for SOD 856 U min−1 gHb−1, 95% CI 397–1316, and 556 U min−1 gHb−1, 95% CI 30–1082, respectively; and for antioxidant status 0.83 mmol l−1 plasma, 95% CI 0.30–1.36, and 0.63 mmol l−1 plasma, 95% CI 0.02–1.24, respectively). GR activity was significantly lower in groups 3 and 2 in comparison with group 1 (mean differences 3.44 U min−1 gHb−1, 95% CI 0.63–6.25, and 5.64 U min−1 gHb−1, 95% CI 2.90–8.38, respectively). Using multiple regression analysis, paracetamol dose was found to be the only independent variable affecting GR, GST and SOD activities (P = 0.007, 0.003 and 0.008, respectively).
Conclusions
In febrile children, treatment with repeated supratherapeutic doses of paracetamol is associated with reduced antioxidant status and erythrocyte glutathione concentrations. These significant changes may indicate an increased risk for hepatotoxicity and liver damage.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>12630972</pmid><doi>10.1046/j.1365-2125.2003.01723.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-5251 |
ispartof | British journal of clinical pharmacology, 2003-03, Vol.55 (3), p.234-240 |
issn | 0306-5251 1365-2125 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1884208 |
source | MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Acetaminophen - administration & dosage antioxidant status Antioxidants - metabolism Biological and medical sciences Child Child, Preschool Clinical Toxicology Drug toxicity and drugs side effects treatment Erythrocytes - enzymology febrile children Female Glutathione - metabolism glutathione changes Glutathione Peroxidase - blood Glutathione Reductase - blood Glutathione Transferase - blood glutathione‐dependent enzymes Humans Infant Male Medical sciences Pharmacology. Drug treatments Prospective Studies repeated paracetamol Superoxide Dismutase - blood Toxicity: digestive system |
title | Glutathione, glutathione‐dependent enzymes and antioxidant status in erythrocytes from children treated with high‐dose paracetamol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A52%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glutathione,%20glutathione%E2%80%90dependent%20enzymes%20and%20antioxidant%20status%20in%20erythrocytes%20from%20children%20treated%20with%20high%E2%80%90dose%20paracetamol&rft.jtitle=British%20journal%20of%20clinical%20pharmacology&rft.au=Kozer,%20Eran&rft.date=2003-03&rft.volume=55&rft.issue=3&rft.spage=234&rft.epage=240&rft.pages=234-240&rft.issn=0306-5251&rft.eissn=1365-2125&rft.coden=BCPHBM&rft_id=info:doi/10.1046/j.1365-2125.2003.01723.x&rft_dat=%3Cwiley_pubme%3EBCP1723%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12630972&rfr_iscdi=true |